Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
about
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Pathway-Specific Dopamine Abnormalities in Schizophrenia.Glutamate and dopamine in schizophrenia: an update for the 21st centuryConnectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography.Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.The neurobiology and treatment of first-episode schizophrenia.The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
P2860
Q30437188-A19E82A7-4143-44B9-B79D-9FFFCBE1B346Q31108616-0B7966C5-E498-4468-9906-31931D03E0CAQ34527656-88DCE972-47F9-4A60-BCAE-45D4CBB1F0F2Q36992322-84B720EF-1248-4804-ACC2-C7482D18785FQ37688287-F85E4748-C8C9-41A7-A523-9B0BC804422EQ38219577-DF2496A1-7F1D-401D-AF19-39AD65F5D817Q38232366-1D771A96-068B-4D8A-B193-9010B403C385Q38976291-04157CB6-82B1-4D87-B75B-EFF96CD5F9D4Q39037300-A0CA3EB2-9D5A-47B1-92D8-56D02F9301ABQ41867856-0FF4EE2E-70BC-4B29-B9EC-21586AA18634Q47098182-2D5A71FA-8458-4595-9158-EDD6E37DEE42Q47596297-F6D61BFF-5A04-4B32-BFD4-CC853C00C57DQ47920400-EF55476F-8E74-4A44-83FC-FC5B861E8DA7Q50079750-634A242E-33A7-4D75-956A-F27167B7A481Q50659891-0CED64D5-0A49-49CB-B42F-9D516AFD1F5C
P2860
Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@ast
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@en
type
label
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@ast
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@en
prefLabel
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@ast
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@en
P2093
P2860
P50
P356
P1476
Dopamine D2 and D3 binding in ...... le performing a cognitive task
@en
P2093
Alan A Wilson
Ivonne Suridjan
Pablo Rusjan
P2860
P304
P356
10.1503/JPN.110181
P577
2013-03-01T00:00:00Z